focus -WSS

focus

author：Wikipedia 2025-09-29 13:31:20 - browse：8

SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and reviewed by STAT.

The layoffs, which began last Wednesday, impact research teams across the company’s California sites in San Diego and Foster City, as well as locations in Madison, Wisconsin; Singapore; and the United Kingdom. Alex Aravanis, the company’s chief technology officer, noted in an internal message that these cuts affect a tenth of research and development staff. The company’s also planning to shut down all lab-based research and development work in Foster City, according to a note from Steve Barnard, vice president of technology development.

Barnard’s note mentions that all affected employees have already been notified. And a separate message from interim CEO Charles Dadswell makes clear last week’s layoffs won’t be the last.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Chronically ill young patients struggle to find fertility info

WSS

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

A Theranos scientist

3 medical device trends to watch in 2024

Twill hunts for pharma partner to market its depression app

Manchin plays down potential 3rd

Johnson & Johnson sues to stop Medicare negotiation

focus

focus

focus

Medicare proposal to cover medical devices draws a mixed reaction

UCB departs biotech trade group BIO

In age of alternative facts, a scholarly course on calling out crap

Ahead of JPM, here's who's profiting most in health care

Guidelines to prevent youth baseball injuries need more muscle

A Theranos scientist

Sports medicine is finally prioritizing gender equality

Johnson & Johnson sues to stop Medicare negotiation

Continuity nursing helped my family in our darkest PICU moments

J&J to buy cancer drug developer Ambrx Biopharma

leisure time

Goldman Sachs launches $650M fund for life science investments

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

US soldier in North Korean custody after crossing DMZ line

JPM: CVS says Medicare Advantage patients are impacting profits

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

A look at other Americans who have crossed into North Korea over the years

entertainment

hotspot

hotspot

focus